Y-Intercept (HK)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.2M | Buy |
+198,762
| New | +$9.2M | 0.23% | 82 |
|
|
2025
Q1 | – | Sell |
-50,867
| Closed | -$2.88M | – | 1217 |
|
|
2024
Q4 | $2.88M | Buy |
+50,867
| New | +$2.88M | 0.19% | 135 |
|
|
2024
Q3 | – | Sell |
-46,167
| Closed | -$1.92M | – | 1329 |
|
|
2024
Q2 | $1.92M | Buy |
+46,167
| New | +$1.92M | 0.11% | 261 |
|
|
2024
Q1 | – | Sell |
-31,916
| Closed | -$1.64M | – | 1380 |
|
|
2023
Q4 | $1.64M | Buy |
31,916
+18,897
| +145% | +$970K | 0.15% | 180 |
|
|
2023
Q3 | $756K | Sell |
13,019
-73,577
| -85% | -$4.27M | 0.07% | 406 |
|
|
2023
Q2 | $5.54M | Buy |
+86,596
| New | +$5.54M | 0.59% | 4 |
|
|
2023
Q1 | – | Sell |
-60,782
| Closed | -$4.37M | – | 1190 |
|
|
2022
Q4 | $4.37M | Buy |
+60,782
| New | +$4.37M | 0.64% | 4 |
|
|
2022
Q3 | – | Sell |
-50,915
| Closed | -$3.92M | – | 969 |
|
|
2022
Q2 | $3.92M | Buy |
50,915
+32,009
| +169% | +$2.46M | 0.52% | 28 |
|
|
2022
Q1 | $1.38M | Buy |
+18,906
| New | +$1.38M | 0.32% | 66 |
|
|
2021
Q4 | – | Sell |
-14,814
| Closed | -$877K | – | 594 |
|
|
2021
Q3 | $877K | Sell |
14,814
-5,768
| -28% | -$341K | 0.16% | 206 |
|
|
2021
Q2 | $1.38M | Buy |
20,582
+4,764
| +30% | +$318K | 0.35% | 46 |
|
|
2021
Q1 | $1M | Buy |
15,818
+10,310
| +187% | +$652K | 0.27% | 91 |
|
|
2020
Q4 | $341K | Buy |
+5,508
| New | +$341K | 0.14% | 268 |
|